Patents by Inventor Kathleen Dungan

Kathleen Dungan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of estimation of blood glucose excursions in diabetic patients using 1,5-anhydroglucitol (1,5-AG) assay
    Patent number: 8178312
    Abstract: The invention is a method of measuring blood glucose excursions in general, and postprandial hyperglycemia in diabetic patients in particular, by the 1,5-anhydroglucitol assay (1,5-AG) or A1C/1,5-AG assay combination. 1,5-AG levels and percent changes of 1,5-AG levels in short period are indicative of differing postmeal glucose levels in moderately-controlled diabetic patients with similar A1C levels. Thereby 1,5-AG assay is useful to identify diabetic patients who may be at risk for cardiovascular complications which would not be identifiable by A1C levels alone. Furthermore, ratios of A1C divided by 1,5-AG in each patient are superior indicators to 1,5-AG levels.
    Type: Grant
    Filed: April 21, 2006
    Date of Patent: May 15, 2012
    Assignees: Nippon Kayaku Kabushiki Kaisha, Toyota Tsusho America, Inc.
    Inventors: John B. Buse, Kathleen Dungan, Steven D. Wittlin, Eric A. Button, Shuhei Kato, Toshio Tanabe
  • 1,5-Anhydroglucitol (1,5-Ag) Assay and A1C/1,5-Ag Assay Combination For Measuring Blood Glucose Excursions in General and Postprandial Hyperglycemia in Diabetic Patients
    Publication number: 20080187943
    Abstract: The invention is a method of measuring blood glucose excursions in general, and postprandial hyperglycemia in diabetic patients in particular, by the 1,5-anhydroglucitol assay (1,5-AG) or A1C/1,5-AG assay combination. 1,5-AG levels and percent changes of 1,5-AG levels in short period are indicative of differing postmeal glucose levels in moderately-controlled diabetic patients with similar A1C levels. Thereby 1,5-AG assay is useful to identify diabetic patients who may be at risk for cardiovascular complications which would not be identifiable by A1C levels alone. Furthermore, ratios of A1C divided by 1,5-AG in each patient are superior indicators to 1,5-AG levels.
    Type: Application
    Filed: April 21, 2006
    Publication date: August 7, 2008
    Applicants: Nippon Kayaku Kabushiki Kisha, Toyota Tsusho America Inc.
    Inventors: John B. Buse, Kathleen Dungan, Steven D. Wittlin, Eric A. Button, Shuhei Kato, Toshio Tanabe